• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 HOME TEST; LATERAL FLOW IMMUNOASSAY IVD OF COVID-19

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 HOME TEST; LATERAL FLOW IMMUNOASSAY IVD OF COVID-19 Back to Search Results
Catalog Number 195100
Device Problem Use of Device Problem (1670)
Patient Problem Unspecified Tissue Injury (4559)
Event Date 07/05/2021
Event Type  Injury  
Manufacturer Narrative
The investigation is still in progress.A supplemental report will be provided after completion.
 
Event Description
The consumer reported sustaining a nasal injury while using the binaxnow covid-19 home test.The consumer reported an unspecified amount blood on the swab.(b)(6) reported that it was unclear if the consumer's nasal was swabbed twice.(b)(6) also, reported that it appeared the proctor stopped the session before any testing could take place so no actual testing occurred.However, an invalid result was reported.Although requested, no additional patient information, including treatment and outcome, was provided.
 
Manufacturer Narrative
The supplemental report is being submitted to provide additional information snd correct the pma/510k number from eua(b)(4) to eua(b)(4).Additional information: a product deficiency was not reported or identified.According to the package insert in195100 v.5.0: reagents and materials extraction reagent (1 or 2): bottle containing <1 ml of extraction reagent precautions invalid results can occur when an insufficient volume of extraction reagent is added to the test card.To ensure delivery of adequate volume, hold vial vertically, 1/2 inch above the swab well, and add drops slowly.Directions for running the binaxnow¿ covid-19 ag card home test 4.Apply fluid to top hole a.Remove dropper bottle cap.B.Hold dropper bottle straight over top hole, not at an angle.C.Put 6 drops into top hole.Do not touch card with tip.The product will continue to be monitored and tracked.
 
Manufacturer Narrative
The supplemental report is being submitted to correct the previously reported event.Corrected data: b4- initial report date of this report should be 30-jul-2021.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BINAXNOW COVID-19 HOME TEST
Type of Device
LATERAL FLOW IMMUNOASSAY IVD OF COVID-19
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough,
ME 04074
Manufacturer Contact
erina marshall
10 southgate road
scarborough, ME 04074
MDR Report Key12257077
MDR Text Key264728062
Report Number1221359-2021-02121
Device Sequence Number1
Product Code QKP
UDI-Device Identifier00811877011330
UDI-Public01008118770113301721100310142400
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EUA203107
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 11/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/31/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number195100
Device Lot Number142400
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received11/28/2022
Was Device Evaluated by Manufacturer? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient SexFemale
-
-